SCHEMBL6596130

SCHEMBL6596130

CC(C)(C)N1CCC[C@H](OC(N)=O)C1=O

nearest known ligand 0.40

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.40
DPP4 P27487 1/20 0.32
DPP8 Q6V1X1 1/20 0.32
DPP7 Q9UHL4 1/20 0.32
POLB P06746 1/20 0.32
ENO1 P06733 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28689770 1.00 ATM (0.40) ATMDPP4DPP8DPP7POLB
SCHEMBL6608359 0.95 ATM (0.39) ATMDPP4DPP8DPP7POLB
SCHEMBL6603982 0.95 ATM (0.39) ATMDPP4DPP8DPP7POLB
SCHEMBL6596152 0.92 ATM (0.43) ATMPOLBMAPT
SCHEMBL28764312 0.92 ATM (0.43) ATMPOLBMAPT
SCHEMBL14676453 0.92 ATM (0.43) ATMPOLBMAPT
SCHEMBL14676458 0.79 ATM (0.33) ATM
SCHEMBL29117209 0.73 ATM (0.35) ATMMAPT
SCHEMBL15536942 0.73 ATM (0.35) ATMMAPT
SCHEMBL23917060 0.71 POLB (0.34) DPP4DPP8DPP7POLBENO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1156803-A4 LACTAM INHIBITORS OF FXa AND METHOD BRISTOL MYERS SQUIBB CO (US) 2004-03-17 EP disclosed
EP-1294716-A1 LACTAM INHIBITORS OF FACTOR XA AND METHOD Bristol-Myers Squibb Company (US) 2003-03-26 EP disclosed
WO-2001096331-A1 LACTAM INHIBITORS OF FACTOR XA AND METHOD BRISTOL-MYERS SQUIBB COMPANY (US) 2001-12-20 WO disclosed
EP-1156803-A1 LACTAM INHIBITORS OF FXa AND METHOD BRISTOL-MYERS SQUIBB COMPANY (US) 2001-11-28 EP disclosed
WO-2000047207-A1 LACTAM INHIBITORS OF FXa AND METHOD BRISTOL-MYERS SQUIBB COMPANY (US) 2000-08-17 WO disclosed